Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry

1. Carretero, G.
2. Ferrandiz, C.
3. Dauden, E.
4. Vanaclocha Sebastián, F.
5. Gómez-García, F.J.
6. Herrera-Ceballos, E.
7. De La Cueva-Dobao, P.
8. Belinchón, I.
9. Sánchez-Carazo, J.L.
10. Alsina-Gibert, M.
11. López-Estebaranz, J.L.
12. Ferrán, M.
13. Torrado, R.
14. Carrascosa, J.M.
15. Carazo, C.
16. Rivera, R.
17. Jiménez-Puya, R.
18. García-Doval, I.